Anti-viral compounds

Details Anti-viral compounds Anti-viral compounds

2011-03-29

2011-03-29

Wilson, James O (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

Reexamination Certificate

active

07915411

ABSTRACT:
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

REFERENCES:
patent: 3021332 (1962-02-01), Hitchings et al.
patent: 4871851 (1989-10-01), Beck
patent: 5034393 (1991-07-01), Hackler et al.
patent: 5350749 (1994-09-01), Hackler et al.
patent: 5464781 (1995-11-01), Armitage et al.
patent: 5654307 (1997-08-01), Bridges et al.
patent: 5925644 (1999-07-01), Jakobi et al.
patent: 5965563 (1999-10-01), Buzzetti et al.
patent: 6130217 (2000-10-01), Arnold et al.
patent: 6169091 (2001-01-01), Cockerill et al.
patent: 6174889 (2001-01-01), Cockerill et al.
patent: 6184226 (2001-02-01), Chakravarty et al.
patent: 6277989 (2001-08-01), Chakravarty et al.
patent: 6284764 (2001-09-01), Kath et al.
patent: 6323180 (2001-11-01), Llinas-Brunet et al.
patent: 6348587 (2002-02-01), Schinazi et al.
patent: 6395733 (2002-05-01), Arnold et al.
patent: 6413971 (2002-07-01), Arnold et al.
patent: 6476031 (2002-11-01), Chakravarty et al.
patent: 6541481 (2003-04-01), Kath et al.
patent: 6610677 (2003-08-01), Davies et al.
patent: 6703403 (2004-03-01), Norbeck et al.
patent: 6703421 (2004-03-01), Nunokawa et al.
patent: 6723726 (2004-04-01), Cockerill et al.
patent: 6784174 (2004-08-01), Cumming
patent: 6809097 (2004-10-01), Thomas et al.
patent: 6903096 (2005-06-01), Chakravarty et al.
patent: 7037913 (2006-05-01), Wang et al.
patent: 7183302 (2007-02-01), Romine et al.
patent: 2003/0125343 (2003-07-01), Gambacorti-Passerini et al.
patent: 2004/0242604 (2004-12-01), Bhattacharya et al.
patent: 2004/0265792 (2004-12-01), Glenn et al.
patent: 2005/0075331 (2005-04-01), Pratt et al.
patent: 2005/0090522 (2005-04-01), Wang et al.
patent: 2005/0107364 (2005-05-01), Hutchinson et al.
patent: 2005/0215575 (2005-09-01), Bakthavatchalam et al.
patent: 2006/0035965 (2006-02-01), Dalton et al.
patent: 2007/0232627 (2007-10-01), Betebenner et al.
patent: 2007/1023264 (2007-10-01), Rockway et al.
patent: 404355 (1990-12-01), None
patent: 0 414 386 (1991-02-01), None
patent: 0 912 570 (1999-05-01), None
patent: 1 162 196 (2001-12-01), None
patent: 2009217 (1989-09-01), None
patent: 774094 (1957-05-01), None
patent: 47025076 (1972-07-01), None
patent: 93/13097 (1993-07-01), None
patent: 95/00511 (1995-01-01), None
patent: 95/19774 (1995-07-01), None
patent: 96/09294 (1996-03-01), None
patent: 96/40142 (1996-12-01), None
patent: 97/13771 (1997-04-01), None
patent: 98/02428 (1998-01-01), None
patent: 98/02437 (1998-01-01), None
patent: 98/02438 (1998-01-01), None
patent: 98/05661 (1998-02-01), None
patent: 98/08846 (1998-03-01), None
patent: 98/13350 (1998-04-01), None
patent: 98/22444 (1998-05-01), None
patent: 98/23613 (1998-06-01), None
patent: 9846605 (1998-10-01), None
patent: 99/59587 (1999-11-01), None
patent: 00/12497 (2000-03-01), None
patent: 00/44728 (2000-08-01), None
patent: 00/56738 (2000-09-01), None
patent: 01/32153 (2001-05-01), None
patent: 01/32632 (2001-05-01), None
patent: 01/57040 (2001-08-01), None
patent: 01/60315 (2001-08-01), None
patent: 01/90121 (2001-11-01), None
patent: 02/04425 (2002-01-01), None
patent: 03051366 (2003-06-01), None
patent: 03059913 (2003-07-01), None
patent: 03062209 (2003-07-01), None
patent: 03097615 (2003-11-01), None
patent: 2004/055004 (2004-01-01), None
patent: 2004/014313 (2004-02-01), None
patent: 2004/014852 (2004-02-01), None
patent: 2004/024693 (2004-03-01), None
patent: 2004/047818 (2004-06-01), None
patent: 2004055003 (2004-07-01), None
patent: 2004055004 (2004-07-01), None
patent: 2004/065392 (2004-08-01), None
patent: 2004071460 (2004-08-01), None
patent: 2004/087056 (2004-10-01), None
patent: 2005/007652 (2005-01-01), None
patent: 2005003100 (2005-01-01), None
patent: 2005023807 (2005-03-01), None
patent: 2005032481 (2005-04-01), None
patent: 2005/047288 (2005-05-01), None
patent: 2005042498 (2005-05-01), None
patent: 2005049033 (2005-09-01), None
patent: 2005082865 (2005-09-01), None
patent: 2005087227 (2005-09-01), None
patent: 2005/105761 (2005-11-01), None
patent: 2006/012333 (2006-02-01), None
patent: 2006/035061 (2006-04-01), None
patent: 2006/038039 (2006-04-01), None
patent: 2006067614 (2006-06-01), None
patent: 2006071875 (2006-07-01), None
patent: 2006100310 (2006-09-01), None
patent: 2006105063 (2006-10-01), None
patent: 2006/120251 (2006-11-01), None
patent: 2006/120252 (2006-11-01), None
patent: 2006120252 (2006-11-01), None
patent: 2007/035010 (2007-03-01), None
patent: 2007060404 (2007-05-01), None
patent: WO-2007076035 (2007-07-01), None
Barlin et al., “Potential Antimalarials. I 1,8-Naphthyridines, STN Accession No. 1984:530611, Document No. 101:130611 ,” Abstract of Australian Journal of Chemistry, vol. 37 (5), pp. 1065-1173, 1984.
Dorwald F.Z., “Side Reactions in Organic Synthesis—a Guid to Successful Synthesis Design,” pp. 9-16 , 2005.
International Search Report for application No. PCT/US07/088027, Mailed on Oct. 24, 2008, 1 page.
Livi et al. , “Farmaco, STN Document No. 86:89704; Abstract of Edizione Scientifica ,” vol. 31 (11), pp. 797-808, 1976.
Martini C. et al., “Specific Inhibition of Benzodiazepine Receptor Binding by Some 1,2,3-Triazole Derivatives,STN Accession No. 1989:50722 Document No. 110:50722,” Abstract of Journal of Pharmaceutical Sciences, vol. 77 (11), pp. 977-980, 1988.
US Office Action dated Mar. 20, 2008 from U.S. Appl. No. 11/613,810, filed Dec. 20, 2006.
US Office Action dated Apr. 23, 2008 from U.S. Appl. No. 11/613,836, filed Dec. 20, 2006.
US Office Action dated Nov. 4, 2008 from U.S. Appl. No. 11/613,836, filed Dec. 20, 2006.
US Office Action dated Dec. 5, 2008 from U.S. Appl. No. 11/613,810, filed Dec. 20, 2006.
US Office Action dated Jul. 7, 2009 from U.S. Appl. No. 11/613,836, filed Dec. 20, 2006.
US Office Action dated Sep. 4, 2009 from U.S. Appl. No. 11/613,810, filed Dec. 20, 2006.
USPQ, “Grahamv.John Deere Co. of Kansas City”, USPQ, 148:459-478 (1966).
Blight, K.J., et al., “Efficient Initiation of HCV RNA Replication in Cell Culture”,Science, 290:1972-1974 (2000).
Bundgaard, H., “Design of prodrugs”, pp. 7-9 & 21-24 (1985).
Cortese, F. & Bauman, L., “A Synthesis of Conjugatred Bile Acids. I. Glycochotic Acid”,JACS, 57:1393-1395 (1935).
Cross, L.C. & Klyne, W., “Rules for the Nomenclature of Organic Chemistry—Section E: Stereochemistry”,Pure Appl. Chem., 45:11-30 (1976).
Das, S., et al., “A Small yeast RNA Blocks Hepatitis C Virus Internal Ribosome Entry Site (HCV IRES)-Mediated Translation and Inhibits Replication of a Chimeric Poliovirus under Translational control of the HCV IRES Element”,J of Virology, 72(7):5638-5647 (1998).
Deeb, A., et al., “Pyridazine Derivatives and Related Comp9unds Part 5. Pyrazolo[3,4-c]Pyridazine: Synthesis and Some Reactoins”,Heterocycles, 32(5):895-900 (1991).
Gomtsyan, A., et al., “Design, Synthesis, and Structure-Activity Relationship of 6-Alkynylpyrimidines as Potent Adenosine Kinase Inhibitors”,J. Med Chem., 45:3639-3648 (2002).
Greene & Wuts,Protective Groups in Organic Synthesis, 3rdEd.:Tbl of Cont., (1999).
Hoover, J.E.,Remington's Pharmaceutical Sciences, Tbl of Cont., (1975).
Ikeda, M., et al., “Selectable Subgenomic and Genome-Length Dicistronic RNAs Derived from an Infectious Molecular Clone of the HCV-N Strain of Hepatitis C Virus Replicate Efficiently in Clutured Huh7 Cells”,J. of Virology, 76(6):2997-3006 (2002).
Jacques, et al.,Enantiomers, Racemates, and Resolutions, Tble of Cont., (1981).
Janout, V., et al., “Design and Synthesis of Molecular Umbrellas”,J. Am. Chem. Soc., 119:640-647 (1997).
Lieberman, H.A. & Lachman, L.,Pharmaceut

Affiliated with

Also associated with

Rating

Anti-viral compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-viral compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-viral compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2762402